Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F. M., Remme, W. J., Cody, R. J., Castaigne, A., Pérez, A. J. P., Palensky, J., & Wittes, J. T. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604

New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia

Cruz, C. S., Cruz, L. S., Domingues, G. S., & de Souza, C. A. M. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.4.677 · Cited by 5

Angiotensin-Converting Enzyme Inhibitors

Sica, D. A., & Gehr, T. W. B. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50155-1 · Cited by 5

CE

Norton, J. M., Newman, E. P., Romancito, G., Mahooty, S., Kuracina, T. A., & Narva, A. S. (2017) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000513259.90613.27 · Cited by 5

Prevalence and clinical correlates of hyperkalemia in stable kidney transplant recipients

Bussalino, E., Panaro, L., Marsano, L., Bellino, D., Ravera, M., & Paoletti, E. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02649-4 · Cited by 5

Patiromer utilization in patients with advanced chronic kidney disease under nephrology care in Germany

Pecoits‐Filho, R., McCullough, K. P., Muenz, D. G., Quinn, C. M., Budden, J., Golden, J., de Arellano, A. R., Tillmann, F.-P., Duttlinger, J., Cálice-Silva, V., et al. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac209 · Cited by 5

Hiperpotassemia na vigência de espironolactona em pacientes com insuficiência cardíaca descompensada

Lima, M., Ochiai, M. E., Cardoso, J. N., Morgado, P. C., Munhoz, R. T., & Barretto, A. C. P. (2008) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2008001500009 · Cited by 5

Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients

Trachtman, H. (2011) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s17265 · Cited by 5

Eicosanoids and the Kidney

McGiff, J. C., & Ferreri, N. R. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50017-6 · Cited by 5

Clinical Disorders of Hyperkalemia

Kamel, K. S., Lin, S., & Halperin, M. L. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50052-8 · Cited by 5

A nephrologist’s point of view on sodium-glucose linked transporter-2 inhibitors: not all that glitters is gold

Musetti, C., Quaglia, M., & Stratta, P. (2014) · Kidney International · doi:10.1038/ki.2014.42 · Cited by 5

Zirconium Cyclosilicate for Treatment of Hyperkalemia

Dixon, B. S. (2014) · JAMA · doi:10.1001/jama.2014.15736 · Cited by 5

Amiloride: the “new” renal tonic?

Warnock, D. G. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00237.2015 · Cited by 5

Cyclosporine nephrotoxicity and early posttransplant hyperkalemia in living-donor renal recipients: report of 4 cases.

Pavleska-Kuzmanovska, S., Popov, Z., Ivanovski, O., Ristovska, V., Masin‐Spasovska, J., Rambabova-Busljetic, I., & Ivanovski, N. (2014) · Experimental and Clinical Transplantation · doi:10.6002/ect.2013.0159 · Cited by 5

Improvement of Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension

Warnock, D. G., & Bell, P. D. (2005) · Hypertension · doi:10.1161/01.hyp.0000179583.64413.c1 · Cited by 5

Cell Surface Ion-Seq: Potassium Ion Monitoring in the Colorectal Cancer Cellular Microenvironment Based on Split G-quadruplex Probe

Huang, Z., Shi, X., Yang, Y., Ma, W., Li, H., Jin, Z., Feng, Y., Luo, C., Zheng, L., Du, Z., et al. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c01472 · Cited by 4

Efficacy and Safety of Baxdrostat in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Wadhwani, A., Khasbage, S. U., Zade, S. R., Singh, M. P., Keche, Y. N., & Ahire, P. M. (2026) · Cureus · doi:10.7759/cureus.104160 · Cited by 4

Short-term prognosis of changes in plasma potassium following an episode of hyperkalaemia in patients with chronic heart failure

Jønsson, S. S., Sørensen, S. A., Krøgh, S. T., Melgaard, D., Søgaard, P., Søndergaard, M. M., Leutscher, P. D. C., Kragholm, K. H., Aldahl, M., Torp-Pedersen, C. T., et al. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.07.031 · Cited by 4

High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐Converting Enzyme Inhibitor Initiators

Ndai, A. M., Smith, K. M., Keshwani, S., Choi, J., Luvera, M., Hunter, J., Galvan, R., Beachy, T., Molk, M., Wright, S., et al. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70132 · Cited by 4

Ensuring Patient Safety During the Transition to ESRD

Wagner, L.-A., & Fink, J. C. (2017) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.12.009 · Cited by 4

Practical guidance for the use of potassium binders in the management of hyperkalaemia in patients with heart failure and/or chronic kidney disease

Campbell, P. C., McKeveney, P., Donegan, K., Ataliotis, C., Patton, C., & Mullan, R. N. (2021) · British Journal of Hospital Medicine · doi:10.12968/hmed.2021.0215 · Cited by 4

The Impact of Potassium Binders on Mortality in Patients with Hyperkalemia: A Single-Center Study

Nagasu, H., Tokuyama, A., Kanda, E., Itano, S., Kishi, S., Sasaki, T., & Kashihara, N. (2023) · Kidney and Dialysis · doi:10.3390/kidneydial3030022 · Cited by 4

Impact of treatment of hyperkalaemia on quality of life: design of a prospective observational cohort study of long-term management of hyperkalaemia in patients with chronic kidney disease or chronic heart failure in Japan

Shibagaki, Y., Yamazaki, H., Wakita, T., Ware, J. E., Wang, J., Ônishi, Y., Yajima, T., Sada, K., Yamamoto, Y., & Fukuhara, S. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074090 · Cited by 4

Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study

Mathieson, L., Severn, A., & Guthrie, B. (2013) · Scottish Medical Journal · doi:10.1177/0036933013482634 · Cited by 4

Serum Potassium in Dual Renin-Angiotensin-Aldosterone System Blockade

Seliger, S. L., & Fried, L. F. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12411213 · Cited by 4

Complications and management of hyperkalemia: implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer

Noureddine, L. A., & Dixon, B. S. (2015) · Clinical Investigation · doi:10.4155/cli.15.48 · Cited by 4

Renal complications of hematopoietic stem cell transplantation

Humphreys, B. D. (2010) · Oxford University Press eBooks · doi:10.1093/med/9780199580194.003.0008 · Cited by 4

Alterations in Serum Electrolyte Homeostasis in Type-2 Diabetes Mellitus Patients - A Cross-Sectional Study in VIMSAR, Burla

Pattanaik, L., Acharya, M., Yadav, M. K., Mishra, P. K., & Nayak, M. (2020) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2020/641 · Cited by 4

Patiromer

Cada, D. J., Dang, J., & Baker, D. E. (2016) · Hospital Pharmacy · doi:10.1310/hpj5104-328 · Cited by 4

Case Studies and Enrichment References

Bhagavan, N. V., & Ha, C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-095461-2.00038-2 · Cited by 4

Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management

Krishnan, S. K., & Lepor, N. E. (2016) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm17s1s0002 · Cited by 4

Statin Therapy Is Associated With Improved Survival in Ischemic and Non‐Ischemic Heart Failure

Ip, J. H., Kantipudi, S., Khasnis, A. A., Cholia, A., & Dickinson, M. J. (2004) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2004.02816.x · Cited by 4

Review: Dual blockade of the renin angiotensin system in diabetes — rationale and risks

Kumar, R., & Winocour, P. H. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050050501 · Cited by 4

Aldosterone Antagonists in Heart Failure

Miller, S., & Alvarez, R. (2013) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3182675e2a · Cited by 4

¿Cómo realizar la búsqueda de enfermedad renal en pacientes con enfermedad cardiovascular?

Teruel, J. L. (2009) · Medicina Clínica · doi:10.1016/s0025-7753(09)70956-x · Cited by 4

New drugs to prevent and treat hyperkalemia

Lepage, L., Desforges, K., & Lafrance, J. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000272 · Cited by 4

Erfolgreiche Reanimation einer Patientin mit hyperkaliämischem Herzstillstand durch notfallmäßige Hämodiafiltration

Gütlich, D., Hochscherf, M., & Hopf, H. (2005) · Der Anaesthesist · doi:10.1007/s00101-005-0868-4 · Cited by 4

Economic evaluation of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices (PINCER)

Elliott, R. A., Putman, K. D., Franklin, M. K., Verhaeghe, N., Annemans, L., Eden, M., Hayre, J., Rodgers, S., Cantrill, J. A., Armstrong, S., et al. (2013) · Research Explorer (The University of Manchester) · doi:10.13140/2.1.2558.9765 · Cited by 4

Renal Protection in Chronic Kidney Disease

Hanes, D. S., & Weir, M. R. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50115-0 · Cited by 4

Clinical Disorders of Hyperkalemia

Kamel, K. S., Lin, S., Yang, S.-S., & Halperin, M. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00051-3 · Cited by 4

Pathophysiology and clinical management of hyperkalemia in chronic kidney disease

Palmer, B. F., & Clegg, D. J. (2023) · Minerva Medica · doi:10.23736/s0026-4806.23.08465-3 · Cited by 3

A printed potentiometric sensor diving into a paper-based sampler for self-driven and volume-assisted detection of potassium ions in capillary blood

Belcastro, L., Fiore, L., Mazzaracchio, V., & Arduini, F. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.114846 · Cited by 3

Diet-Related Health Recommender Systems for Patients With Chronic Health Conditions: Scoping Review

Dong, X., Yun, B., Pakarinen, A., Zheng, Z., Niu, H., Jin, T., Yuan, C., & Wang, J. (2026) · Journal of Medical Internet Research · doi:10.2196/77726 · Cited by 3

Advances in Hyperkalemia Management and the Emerging Role of Sodium Zirconium Cyclosilicate

Jung, J. A., Juarez, S., Koh, E. S., & Chung, S. (2026) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2026.24.e3 · Cited by 3

Angiotensin-Converting Enzyme Inhibitors

Gradman, A. H., & Traub, D. M. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50083-0 · Cited by 3

Increased Spironolactone Dosing in Acute Heart Failure Alters Potassium Homeostasis but Does not Enhance Decongestion

NATOV, P. S., Ivey-Miranda, J. B., Cox, Z. L., Rao, V. S., Butler, J., Konstam, M. A., Kiernan, M. S., Kapur, N. K., & Testani, J. M. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.06.008 · Cited by 3

Type iv renal tubular acidosis: an emerging type of nephropathy

Quaglia, M., Merlotti, G., Izzo, C., & Stratta, P. (2014) · Giornale di Techniche Nefrologiche e Dialitiche · doi:10.5301/gtnd.2014.12679 · Cited by 3

The clinical relevance of drug–drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice

Nakou, E. S., Marketou, M. E., Vardas, P. E., & PARTHENAKIS, F. I. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1201-y · Cited by 3

Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem

Abrignani, M. G., Gronda, E., Marini, M., Gori, M., Iacoviello, M., Temporelli, P. L., Benvenuto, M., Binaghi, G., Cesaro, A., Maloberti, A., et al. (2024) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07551-7 · Cited by 4

Sulfamethoxazole-Trimethoprim-Induced Hyperkalemia in Hospitalized Patients Using Potassium-Sparing Drugs: An Observational Study

Butterhoff‐Terlingen, M. H., Derijks, H. J., Hermens, W. A. J. J., & van der Linden, P. D. (2024) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2024.259 · Cited by 3

The relationship between renin angiotensin system inhibitor and serum potassium increase during combination therapy with Daclatasvir and Asnaplevir for chronic hepatitis C

Yamazaki, Y., Sato, K., Kakizaki, S., Nagashima, T., Tojima, H., Hashizume, H., Ohyama, T., Horiguchi, N., Kusano, M., & Yamada, M. (2015) · Kanzo · doi:10.2957/kanzo.56.324 · Cited by 3

La néphropathie chronique en présence de diabète

McFarlane, P. A., Gilbert, R. E., MacCallum, L., & Senior, P. A. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.026 · Cited by 4

Étude prospective observationnelle des hyperkaliémies médicamenteuses chez des adultes non dialysés hospitalisés

Onno, C., Rémignon, H., Lagarce, L., Bruhat, C., Tourmen, Y., Subra, J., & Lainé‐Cessac, P. (2007) · Therapies · doi:10.2515/therapie:2007006 · Cited by 3

Spironolactone increases permeability of visceral sheep peritoneum.

Karioti, A., Hatzoglou, C., Zarogiannis, S. G., Deligiorgi, T., Kourti, P., Giannopoulou, M., Arampatzis, S., Liakopoulos, V., Gourgoulianis, K. I., Molyvdas, P.-A., et al. (2009) · PubMed · Cited by 3

Aldosterone antagonists in the treatment and prevention of heart failure

Boxer, R. S., & Dunlap, M. E. (2005) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-005-0027-x · Cited by 3

Exploring Hyperkalemia Risk in Frail Older Patients Using RAAS Inhibitors

Heemels, A. M. J., Gadiot, N. P. P. M., Kerckhoffs, A. P. M., & Goto, N. A. (2025) · Drugs & Aging · doi:10.1007/s40266-024-01171-4 · Cited by 2

Hyperkalemia Is an Underestimated Risk Factor in COPD

Mäenpää, J., Anderson, I., Owen, C. A., Emerath, U., Hughes, R., Sultana, S. R., & Olsson, M. (2025) · International Journal of COPD · doi:10.2147/copd.s490620 · Cited by 2

Comprehensive chemical profiling and quality marker discovery in Shenxiao granules via orthogonal HILIC×RP 2D-LC/MS and mass defect filtering algorithm

Gao, J. F., Li, J., Wang, J., Wang, Y., Yang, D., Zhang, Z., Fu, Z., Wang, F., Wang, L., Chai, S., et al. (2025) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-025-06180-9 · Cited by 2

Resistant Hypertension: Integration of Novel Agents and Interventional Approaches in Clinical Practice

Arriola‐Montenegro, J., Chapoñan-Lavalle, A., Nombera-Aznaran, N., Abdalla, M. S., Bizer, B., Mohan, A., Verdugo, I. A. M., Zardoost, P., Ordaya-Gonzales, K., Rizzo, A. V., et al. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm45429 · Cited by 2

Evolving Mineralocorticoid Receptor Antagonism: a Narrative Review on Differences between Steroidal MRAs, Non-Steroidal MRAs and Aldosterone Synthase Inhibitors in Cardiorenal Disease

Erzeel, J., Es, M. V., Müllens, W., & Martens, P. (2026) · Current Heart Failure Reports · doi:10.1007/s11897-026-00740-5 · Cited by 2

Toll of Chronic Metabolic Acidosis at Molecular, Cellular, and Systemic Levels: A Conceptual Framework to Revisit Type 2 Diabetes (T2D) Pathophysiology

Sater, M. S., & Giha, H. A. (2026) · Biomedicines · doi:10.3390/biomedicines14040901 · Cited by 2

Hyperkalemia of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in hemodialysis: A meta-analysis

Zhang, Q., Luan, H., Wang, L., Zhang, M., Chen, Y., Lv, Y., & Ma, Z. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-1035-1 · Cited by 2

Dual renin–angiotensin system blockade: In patients with single functioning kidney and proteinuria

Robles, N. R., Jiménez, B. R., Gallego, R. H., Ruiz-Calero, R., Casado, E. S., & Cubero, J. J. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.06.002 · Cited by 2

Effect of Excessive Potassium on Muscular Strength: A Case Report

Liu, H. H., & Wellons, M. (2005) · Physical & Occupational Therapy In Geriatrics · doi:10.1080/j148v23n04_04 · Cited by 2

Trastornos electrolíticos inducidos por fármacos y sustancias tóxicas

Escobar, E. C. C., Pérez-Madrid, H., Jiménez-Ospina, L., Cabrera-Rojas, D. L., Palacín-Bernal, N., Sepúlveda-Barbosa, G., Piedrahita, J., Díaz-Vélez, L. F., Quintero-Aguirre, J., & Montoya-Giraldo, M. A. (2020) · Medicina y Laboratorio · doi:10.36384/01232576.352 · Cited by 2

Real-world management of chronic and postprandial hyperkalemia in CKD patients treated with patiromer: a single-center retrospective study

Riccio, E., D’Ercole, A., Sannino, A., Hamzeh, S., Marco, O. D., Capuano, I., Buonanno, P., Rizzo, M., & Pisani, A. (2024) · Journal of Nephrology · doi:10.1007/s40620-024-01897-9 · Cited by 2

Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis

Williams, R., Ford, W., James, A., Thomas, K., & Wong, A. (2024) · Cardiology and Therapy · doi:10.1007/s40119-024-00388-z · Cited by 2

Congestive Heart Failure: Current Treatment and Therapies under Realm of Research

J.Momin, A., & Lotankar, A. R. (2018) · Advances in Pharmacology and Pharmacy · doi:10.13189/app.2018.060204 · Cited by 2

Adjunctive Pharmacologic Therapies in Acute Myocardial Infarction

Bach, R. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52993-8.00012-6 · Cited by 2

Evaluación de la función renal en pacientes hipertensos: subdiagnóstico de la enfermedad renal

Sarcona, E. S., & Díaz, M. G. (2026) · Revista Argentina de Cardiología · doi:10.7775/rac.v73i5.2702 · Cited by 2

Sine-wave pattern on the electrocardiogram and hyperkalaemia

Scarabeo, V., Baccillieri, S., Marco, A. D., de Conti, F., Contessotto, F., & Piovesana, P. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000285314.23530.87 · Cited by 2

Hyperkalemia in hypertensive patients undergoing regular hemodialysis during enalapril and fosinopril therapy

Dimkovic, N. B., Djordjevic, T., Popović, J., Dimković, S., Tirmenštajn‐Janković, B., Živanović, M., Zikic, S., & Bobanovic-Haskovic, J. (2006) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0602044d · Cited by 2

Blood Pressure Medications: ACE-I/ARB and Chronic Kidney Disease

Han, H. (2013) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2013.08.003 · Cited by 2

Heparin-Induced Hyperkalemia in an Extremely-Low-Birth-Weight Infant: A Case Report

Shimokaze, T., Akaba, K., & Saito, E. (2014) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1255 · Cited by 2

An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675

Pitt, B., Zann, V., Roe, C., Jacobs, J. W., Davidson, J. P., Dowd, C., Kumaraswamy, P., Lin, F., Korner, P., Blanks, R. C., et al. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1102 · Cited by 2

Effects of Aqueous Extract of Persea americana (Mill.) Leaf on the Myocardium of Left Ventricle of High Salt Fed Adult Wistar Rat

Ayoola, I. O., Komolafe, O. A., Saka, O. S., Bejide, R. A., & Odukoya, S. O. A. (2018) · Journal of Morphological Sciences · doi:10.1055/s-0038-1660490 · Cited by 2

Core Concepts and Treatment of Metabolic Acidosis

Wiederkehr, M. R., & Moe, O. W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3770-3_8 · Cited by 2

Benefits of Diuretic-Based Low-Cost Antihypertensive Therapy

SIMONE, G. D., & DIVITIIS, O. D. (2005) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/00151642-200512020-00003 · Cited by 2

Adjunctive Pharmacologic Therapies in Acute Myocardial Infarction

Man, J. P., Tymchak, W. J., & Jugdutt, B. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-3773-6.10013-8 · Cited by 2

Study of potential nephroprotective effects of Ramipril versus Alpha lipoic acid against Gentamicin induced nephropathy in rats

Darwish, M. M., & El-Lateef, A. E.-L. S. A. (2018) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2018.20115 · Cited by 2

Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review

Fonseca, C., Brito, D. A., Branco, P. Q., Frazão, J. M., Silva‐Cardoso, J., & Bettencourt, P. (2020) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2020.03.010 · Cited by 2

Emergency Department Presentation of Life-threatening Symptomatic Hyperkalemia From an Angiotensin Receptor Blocker in a Low-risk Individual

Dockery, S., Dupré, A., DeFlorio, P. T., & Murray, B. P. (2022) · Military Medicine · doi:10.1093/milmed/usac376 · Cited by 2

Hyperkalemia and Inhibitors of the Renin–Angiotensin–Aldosterone System

Segal, A. Z. (2004) · New England Journal of Medicine · doi:10.1056/nejm200412023512321 · Cited by 2

Disorders of Potassium Metabolism

Allon, M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5185-5.00012-2 · Cited by 2

Hyporeninemic Hypoaldosteronism

Purohit, S., Corry, D. B., & Tuck, M. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95898-7 · Cited by 2

Renin-Angiotensin System Inhibitors in Advanced CKD: a #NephJC Editorial on STOP-ACEi

Thanabalasingam, S. J., Popa, C. A., Arora, N., Hiremath, S. S., & Teakell, J. M. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2023.100633 · Cited by 2

Nierenerkrankungen

Reister, B., & Keller, F. (2012) · Notfall + Rettungsmedizin · doi:10.1007/s10049-012-1663-9 · Cited by 1

Potassium Metabolism in Chronic Kidney Disease

Palmer, B. F., & Clegg, D. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00040-1 · Cited by 1

Chronic Hyperkalaemia with Patiromer in Haemodialysis: A Single-Center, Prospective Observational Study in the Clinical Practice

Simó, V. E., González, I. T., Vidal, U. L. V., Rubiano, C. G., Guzmán, F. M., Oleas, D., Gallego, V. D., Potau, M. P., Solé, A. S., & Serna, M. R. D. A. (2023) · Austin Journal of Urology · doi:10.26420/austinjurol.2023.1079 · Cited by 1

The masters athlete and use of antihypertensive medications

Wu, A. H., Patzsch, R., & Cornett, A. C. (2024) · Postgraduate Medicine · doi:10.1080/00325481.2024.2426449 · Cited by 1

The Effect of Different Serum Potassium Levels on Progression of Chronic Kidney Disease

Gökmen, İ., & Elçioğlu, Ö. C. (2025) · Akdeniz Medical Journal · doi:10.53394/akd.1482691 · Cited by 1

Real-world insights into hyperkalemia burden and RAASi discontinuation: a cohort study

Almalki, A. H., Sadagah, L. F., Merdad, R. H., Alorainan, N. A., Quqandi, S. M. A., Bukhari, M. A., & Dokhaikh, F. A. A. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2579422 · Cited by 1

Severe Hyperkalemia With Cardiac Conduction Abnormalities in a 92-Year-Old Woman: First Reported Case in Illinois, United States

Adedara, V. O., Kholoki, S., Kassar, K., Amaechi, C. C., Okei, J., Ojo, O. A., Modise, O., & Ashuarrah, B. E. (2025) · Cureus · doi:10.7759/cureus.95662 · Cited by 1

Medical Treatment in Heart Failure with Reduced Ejection Fraction: A Proposed Algorithm Based on the Patient’s Electrolytes and Congestion Status

PARASKEVAIDIS, I. A., Xanthopoulos, A. V., Karamichalakis, N., Triposkiadis, F. K., & Tsougos, E. (2023) · Medical Sciences · doi:10.3390/medsci11020038 · Cited by 1

Clinical Evaluation of QTc Interval Prolongation With the Dual Endothelin Receptor Antagonist Aprocitentan

Sidharta, P. N., Brussee, J. M., Schultz, A., Wierdak, J., & Dingemanse, J. (2025) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484251351135 · Cited by 1

Prognostic Value of Glucose-to-Potassium Ratio in Acute Ischemic Stroke Patients Undergoing Thrombolysis and Its Interaction with Inflammation

Lin, L., Zhang, R., Wang, J., Fan, Y., Xie, W., Yu, B., Lou, J., Pan, Y., Chen, C., Huang, S., et al. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s553110 · Cited by 1

Clinical Evaluation of a Disposable Test Strip for Potassium Level Measurement in Patients Treated with Maintenance Hemodialysis

Park, C. H., Kim, Y. S., Kim, C., Kim, C., Kim, S. W., Lee, K., & Yoo, T. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000934 · Cited by 1

Incidence of hyperkalaemia and major creatinine elevation after renin–angiotensin system inhibitor initiation in a Singapore primary care cohort

Lim, M. W., Szücs, A., Ong, D., & van der Lubbe, S. C. C. (2026) · BMC Family Practice · doi:10.1186/s12875-026-03195-8 · Cited by 1

Association of admission serum potassium levels with mortality according to renal function in coronary artery disease: a prospective cohort study

Ma, Y., Liu, S., Liu, Z., Zhang, J., Song, D., Lv, J., Chen, J., Chen, G., Zheng, W., Ma, J., et al. (2026) · European journal of medical research · doi:10.1186/s40001-026-04140-2 · Cited by 1

SEVERE HYPERKALEMIA: A RETROSPECTIVE ANALYSIS

Yüksel, Ş., Çölbay, M., Acartürk, G., Uslan, İ., Karaman, Ö., Maralcan, M., & Yavuz, Y. (2008) · Electronic Journal of General Medicine · doi:10.29333/ejgm/82582 · Cited by 1

Volumen- und Elektrolytstörungen bei medikamentöser Therapie

Dendorfer, U., & Mann, J. F. E. (2006) · Der Internist · doi:10.1007/s00108-006-1719-3 · Cited by 1

Systematic Review Of Hyperkalemia Due To Angiotensin Enzyme Converting Inhibitors

Aggarwal, S., Topaloglu, H., & Kumar, S. (2015) · Value in Health · doi:10.1016/j.jval.2015.09.898

Systematic Review of Burden of Hyperkalemia due to Angiotensin Enzyme Converting Inhibitors

Aggarwal, S., Kumar, S., & Topaloglu, H. (2016) · Value in Health · doi:10.1016/j.jval.2016.03.082

Hyperkalemia and Inhibitors of the Renin–Angiotensin–Aldosterone System

Segal, A. Z. (2004) · New England Journal of Medicine · doi:10.1056/nejm200412023512321 · Cited by 2

Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Closer Look at Hyperkalemia

Chung, S., & Park, C. W. (2011) · The Korean Journal of Internal Medicine

Hyperkalemia Associated with Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

Raebel, M. A. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00258.x · Cited by 190